System Maintenance Notice

Please note that maintenance work is scheduled between 4 AM and 5 AM - CET. During this time, you may experience reduced performance. Thanks for your patience.

Elio Castagnola is an expert in Infectiology at Istituto Giannina Gaslini (Italy). As of October 2026, ScienceLeadR ranks Elio Castagnola in the top 1% of experts worldwide for Neutropenia, Mycoses and Cytopenia. Elio Castagnola has authored 497 publications, the most recent in 2026, and is an investigator in 6 clinical trials, 2 of them ongoing. SLR score: 1,497 (community average: 125). How the SLR is computed.

LeadR Profile

Elio Castagnola Istituto Giannina Gaslini Italy
1 497 ScienceLeadR Reputation 1497

Unlock

Register Login
Network Map

Infectiology

Subspecialties: Pediatrics - Immunology - Public Health

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Expert Rankings

Top experts on the MeSH terms this expert works on

Organizations

Career arc: 1992 - 2026
Source: PubMed

Istituto Giannina Gaslini

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 497

Citations

Citations: 21 018 1st author: 99 Last author: 119 Unique author: 2

Main journals

J Chemother 26
Bone Marrow Transplant 25
Pediatr Infect Dis J 25
Pediatr Blood Cancer 21
Clin Microbiol Infect 17

Best Journals

J Clin Oncol 3
Lancet Oncol 3
Lancet Infect Dis 1

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Clinical Practice Guideline for Systemic Antibacterial and Antifungal Prophylaxis in Pediatric Patients With Cancer and Hematopoietic Cell Transplant Recipients: 2026 Update.
PMID 42826360 — cells, levofloxacin, neoplasms, transplants, infections		J Clin Oncol Top journal20260
Multicentre outbreak of Candida viswanathii bloodstream infections linked to contaminated milrinone, Italy, April to October 2025.
PMID 42725369 — milrinone, sepsis, communicable diseases, candida, infections		Euro Surveill20260
Liposomal amphotericin B retrospective multicentre study on mycosis prophylaxis (L-AmB_RUSCO): tolerability and safety of extended-dosing primary antifungal prophylaxis in children with newly diagnosed acute myeloid leukaemia.
PMID 42606142 — safety, drug therapy, exanthema, amphotericin b, child		J Antimicrob Chemother20260
Corrigendum to "Redefining ultrasound's role in early diagnosis of hepatosplenic candidiasis during neutropenia: A pediatric case report in solid tumor" [Med. Mycol. Case Rep., 51 (2026) 100777].
PMID 42325298 — early diagnosis, candidiasis, neutropenia, neoplasms, diagnosis		Med Mycol Case Rep20260
High-dose continuous infusion of piperacillin/tazobactam via elastomeric pump in a pediatric patient with Kartagener syndrome: pharmacokinetic target attainment and clinical outcome.
PMID 42223082 — piperacillin, tazobactam drug combination, piperacillin, tazobactam, drug therapy, precision medicine, kartagener syndrome, therapeutics, tissues, infections		J Chemother20260

Clinical Studies 6

Sources: ClinicalTrials, EU CTIS

Synthesis

By phase:

N/A 5
Phase 2 1

By status:

Completed 2
Recruiting 2
Unknown 2

By type:

Observational 5
Interventional 1

By Monocentric/Multicentric:

monocentric 1
multicentric2to4 0
multicentric5to9 0
multicentricup10 5

Main Topics

Cohort/Consortium Investigators 2

Ongoing Clinical Trials

2 ongoing trials started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
A Study to Assess How Vaborem is Taking up in the Body and Tolerated in Paediatric Patients With Gram Negative Infections Including But Not Restricted to Complicated Urinary Tract Infections
NCT06828848 — safety, infant, newborn, urinary tract, urinary tract infections, meropenem, body weight, infections, pharmacokinetics		Phase 2Recruiting2025
Multicenter Italian Cohort Study on Tuberculosis in Pediatric Age
NCT06289660 — latent tuberculosis, cohort studies, tuberculosis, infections		N/ARecruiting2022

LeadR Networks

Main global connection map

Sources: PubMed, OpenAlex, ClinicalTrials, EU CTIS